Study on PK-PD and TDM of Meropenem

Study on PK-PD and TDM of Meropenem - Study on PK-PD & TDM of MEPM

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000014563

Enrollment

Registered

2014-07-15

Start date

2014-08-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infectious disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inpatients treated with meropenem

Exclusion criteria

Exclusion criteria: Nothing

Design outcomes

Primary

Measure	Time frame
%>MIC( ratio of time above MIC to dosing interval) and clinical laboratory data and findings related to infection	—

Countries

Japan

Contacts

Public ContactKimikazu Shinozaki

Kitasato Institute Hospital Division of TDM

shinozakik@pharm.kitasato-u.ac.jp03-5791-6232

Outcome results